Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver

Completed

Conditions studied: Hepatocellular Carcinoma, Metastatic Carcinoma to the Liver

In brief

This project investigates the feasibility of assessing the relative blood volume of carcinomas in patients with Hepatocellular Carcinoma (HCC) and liver metastases from pancreatic or colorectal cancer compared to normal liver from DynaCT acquisitions on an interventional platform.

Key facts

Study ID

NCT02288910

Run by

Rush University Medical Center

People needed

7

Starts

2014-11-01

Expected to finish

2020-07-01

Last updated by the study team

2020-10-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HCC or metastatic liver disease
• Candidate for radioembolization or chemoembolization

You may not qualify if…

• Pregnant
• Iodine allergy

Where it is running

• Rush University Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.